Form 4 for TGTX TG THERAPEUTICS, INC.
Accepted 2024-03-13 00:00:00 ET · period of report 2024-03-12 · accession 0001437749-24-007662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-13 | 2024-03-12 | TGTX | Charney Laurence N | Dir | S - Sale | $15.97 | -22.0K | 215.2K | -9% | -$351.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-12 | S | D | 22,000 | $15.97 | 215,229 | D | — | — | (F1) These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations. (F2) Reflects the weighted average sale price. The range of prices for the shares sold was $15.95 to $16.00. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. (F3) Includes shares of restricted Common Stock, which vest over various time periods. |